SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
October 15, 1996
Innotech, Inc.
------------------------------------------------------
(exact name of registrant as specified in its charter)
Delaware 0-27746 54-1560349
- --------------- ----------- --------------
(State or other (Commission (IRS Employee
jurisdiction File No.) Identification No.)
of incorporation)
5568 Airport Road, Roanoke, Virginia 24012
- ----------------------------------------- --------
(Address of principal executive offices) (Zip code)
Registrant's telephone no., including area code: (540) 362-2520
--------------
TOTAL NUMBER OF PAGES: 3
<PAGE>
Item 5. Other Events.
On October 15, 1996, the Registrant consummated the
purchase of the warrant to acquire 150,000 units of Prism
Ophthalmics, L.L.C. ("Prism") and the purchase of the option to
acquire all of the outstanding equity interests of Prism, as
described in the Current Report on Form 8-K of the Registrant
dated October 2, 1996, filed with the Securities and Exchange
Commission on October 10, 1996 and incorporated herein by
reference.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to be
signed on its behalf by the undersigned thereunto duly
authorized.
INNOTECH, INC.
(Registrant)
Date: October 18, 1996 Ronald D. Blum
---------------------------
Ronald D. Blum
Chairman of the Board and
Chief Executive Officer
